Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy David M. BaguleyPattarawadee Prayuenyong Review Article Open access 21 December 2019 Pages: 245 - 250
Prospective use of the single-mouse experimental design for the evaluation of PLX038A Samson GhiluQilin LiPeter J. Houghton Original Article 11 January 2020 Pages: 251 - 263
Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival Yumiko OtaDaisuke TakahariKensei Yamaguchi Original Article 06 January 2020 Pages: 265 - 272
Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib Zehua WangJianwen GaoCongjian Xu Original Article 06 January 2020 Pages: 273 - 284
The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model Takashi HiguchiNorihiko SugisawaRobert M. Hoffman Original Article 08 November 2019 Pages: 285 - 291
Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation Yidan SunJingjing HuangJiong Hu Original Article 13 December 2019 Pages: 293 - 308
Notch1 and PI3K/Akt signaling blockers DAPT and LY294002 coordinately inhibit metastasis of gastric cancer through mutual enhancement Xingchun PengJianrui ZhouXinsheng Gu Original Article 16 November 2019 Pages: 309 - 320
The antimetastatic activity of orlistat is accompanied by an antitumoral immune response in mouse melanoma Luciana Y. de AlmeidaFlávia S. MarianoEdgard Graner Original Article 20 December 2019 Pages: 321 - 330
Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis Sameh SaberAmal M. H. GhanimEman M. Abd El-Kader Original Article 27 January 2020 Pages: 331 - 343
Pharmacokinetic and toxicodynamic evaluation of 5-fluorouracil administration after major hepatectomy in a rat model Kazuhiro TadaYukio IwashitaMasafumi Inomata Original Article 11 October 2019 Pages: 345 - 352
Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resistant ovarian cancer Ondřej KubečekJiřina MartínkováStanislav Filip Original Article 14 November 2019 Pages: 353 - 365
Anti-tumor activities and mechanism study of α-pinene derivative in vivo and in vitro Lianbao YeXiaoshun ZhangWeiqiang Chen Original Article 03 December 2019 Pages: 367 - 377
6-Gingerol induces cell-cycle G1-phase arrest through AKT–GSK 3β–cyclin D1 pathway in renal-cell carcinoma Shan XuHaibao ZhangLei Li Original Article Open access 12 December 2019 Pages: 379 - 390
Effect of rifampin and itraconazole on the pharmacokinetics of zanubrutinib (a Bruton's tyrosine kinase inhibitor) in Asian and non-Asian healthy subjects Song MuZhiyu TangSrikumar Sahasranaman Original Article Open access 26 December 2019 Pages: 391 - 399
Effect of dual inhibition of histone deacetylase and phosphatidylinositol-3 kinase in Philadelphia chromosome-positive leukemia cells Seiichi OkabeYuko TanakaAkihiko Gotoh Original Article 04 January 2020 Pages: 401 - 412
RETRACTED ARTICLE: MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer Zhongxing LiangAmber FengHyunsuk Shim Original Article 06 January 2020 Pages: 413 - 423
Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma Zeeshan AhmadBlake A. JacobsonRobert A. Kratzke Original Article 23 January 2020 Pages: 425 - 432
Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3 Chenrong HuangFan XiaLiyan Miao Original Article 05 November 2019 Pages: 433 - 441
The pharmacokinetic interaction between irinotecan and sunitinib Lili JiangLi WangYong Liu Original Article 05 November 2019 Pages: 443 - 448
Improved survival among patients enrolled in oncology phase 1 trials in recent decades Takahiro EbataToshio ShimizuNoboru Yamamoto Original Article 19 November 2019 Pages: 449 - 459
Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapies James R. TonraG. Kenneth LloydLan Huang Short Communication Open access 06 December 2019 Pages: 461 - 468
Characterization and outcomes of patients enrolled to multiple phase I cancer trials Nathan KuehneLina ChenDaniel Shepshelovich Short Communication 08 November 2019 Pages: 469 - 472
PIK3CA mutations and specific treatment: do not forget lessons from RAS mutations and EGFR targeting Gérard Milano Letter to the Editor 22 January 2020 Pages: 473 - 474
Correction to: Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors Samuel J. ReddickOlivia CampagneClinton F. Stewart Correction 07 January 2020 Pages: 475 - 475
